| Andrew Harton |
|
||||||||||||||||||||||||||||||||
2/17/2026Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
2/17/2026Delaware Doctors Work to Reverse Genetic Disease
1/12/2026Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
1/12/2026AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit
3/19/2026
2026 March BioBreakfast
Print Page